Wednesday, 20 March, 2024

Cognizant Collaborates with Nvidia to Enhance Drug Discovery Using AI

Cognizant joins forces with Nvidia to leverage artificial intelligence (AI) for advancing drug discovery processes. Through this partnership, Cognizant aims to harness Nvidia's AI capabilities to accelerate drug development and enhance efficiency in the pharmaceutical industry. By integrating AI into drug discovery workflows, Cognizant and Nvidia seek to revolutionize healthcare research and improve patient outcomes through the development of innovative therapies and treatments.